StockData
Neumora Therapeutics, Inc. logo

Neumora Therapeutics, Inc. (NMRA) income statement

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.37+0.03 (+9.66%)

Close on Nov 18, 2026Market cap $68.92MP/E –Yield –

See a number that looks wrong?